Consumer Options and Pricing Oddities for GLP-1s

In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, breaks down CMS’ proposed 2027 Medicare Advantage rule, challenges facing smaller MA plans, and the shrinking access to GLP-1 medications on ACA marketplaces. He also highlights the evolving dynamics between payers, providers and consumers as policy and costs rapidly shift.